Hej Visste du att du med vår premiumtjänst får fullständig historik i alla grafer, pressmeddelanden och andra notiser för dina favoritbolag direkt som DM i Discord samt en del andra godsaker? Du slipper dessutom störande annonser på sajten. Testa gratis i 14 dagar!

Physitrack PLC — Transactions under Share Buy-back Programme

MARKN.

Physitrack PLC (Nasdaq First North Growth Market Stockholm: PTRK) (“Physitrack” or the “Company”) announced on 21 July 2026 a share buy-back programme, which commenced on 10 August 2026. The Company reports below the transactions undertaken under the programme during the week of 24 August 2026 to 28 August 2026 (inclusive), in accordance with Article 5 of the Market Abuse Regulation (EU) 596/2014 (“MAR”) and Commission Delegated Regulation (EU) 2016/1052.

Summary of transactions

Period24 August 2026 – 28 August 2026
Total shares repurchased during the week6,673
Volume-weighted average price paid (SEK)8.0964
Total consideration paid (SEK)54,027.06
Total shares held by the Company (treasury) following these transactions21,173
Total outstanding shares in the Company16,260,766
Treasury holding as % of issued share capital0.13%

Individual transactions

DateQuantityAverage price (SEK)
2026-08-241,0008.08
2026-08-252,0008.16
2026-08-261,5008.16
2026-08-271,5008.0133
2026-08-286737.9749

 
The buy-back programme is conducted within the safe harbour provided by Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052. The purpose of the programme is to enable the Company to meet its obligations under its employee share plans. The programme is executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details

1. IssuerPhysitrack PLC, LEI 213800PC4QYNWHPCP774
2. Instrument/ISINOrdinary shares / GB00BYX22590
3. Trading venueNasdaq First North Growth Market Stockholm (PTRK)
4. CurrencySEK
5. Purpose of buy-backTo meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR)
6. Executing brokerPareto Securities (non-discretionary mandate)

This disclosure is made in accordance with Physitrack PLC's obligations under Article 5 of MAR and Commission Delegated Regulation (EU) 2016/1052.

Datum 2026-08-31, kl 08:30
Källa MFN